- Filed
- May 22, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 4.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.12M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.52M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$459.72K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$724.82K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $134.68K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$39.56M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$38.71M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $40.99M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $40.18M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $41.07M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $40.27M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $268.9K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $437.75K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $727.16K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $773.54K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.80 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.80 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.02 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $142 |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $24.67K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$661.41K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$930.83K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $10.39K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $9.49K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $45.66K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $32.77K |
| Revenue | Q1 2026 · Mar 31, 2026 | $56.05K |
| Revenue | Q1 2026 · Mar 31, 2025 | $42.26K |
| Capex | Q1 2026 · Mar 31, 2025 | $3.49K |